BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/11/2021 12:05:59 PM | Browse: 794 | Download: 1996
 |
Received |
|
2020-08-11 15:25 |
|
Peer-Review Started |
|
2020-08-11 15:25 |
|
First Decision by Editorial Office Director |
|
2020-12-18 00:41 |
|
Return for Revision |
|
2020-12-18 00:41 |
|
Revised |
|
2020-12-18 19:34 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2021-02-04 03:34 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2021-02-12 04:16 |
|
Articles in Press |
|
2021-02-12 04:16 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2021-03-01 00:30 |
|
Publish the Manuscript Online |
|
2021-03-11 12:05 |
| ISSN |
2218-4333 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Observational Study |
| Article Title |
Thromboembolic events in metastatic testicular cancer treated with cisplatin-based chemotherapy
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Lisa B E Shields, Michael W Daniels, Nataliya Mar and Arash Rezazadeh Kalebasty |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Arash Rezazadeh Kalebasty, MD, Doctor, Doctor, Division of Hematology/Oncology, Department of Medicine, UCI Medical Center, 101 The City Drive South, Zot 4061, Orange, CA 92868, United States. arez@uci.edu |
| Key Words |
Oncology; Testicular cancer; Thromboembolic; Cisplatin; Pulmonary embolism; Thromboprophylaxis |
| Core Tip |
While cisplatin-based chemotherapy has significantly lengthened the survival of patients with testicular germ cell tumor, it is associated with a high rate of thromboembolic events (TEE). We analyzed 68 patients who were diagnosed with testicular germ cell tumor and received platinum-based chemotherapy. A total of 19 (28%) patients experienced a TEE following orchiectomy which occurred during chemotherapy in 13 (68%) of these patients. Patients with a higher pathologic stage (stage III) were significantly more likely to experience a TEE compared to patients with a lower stage. Randomized studies to evaluate the safety and efficacy of prophylactic anticoagulants are necessary in this young patient population generally without medical co-morbidities. |
| Publish Date |
2021-03-11 12:05 |
| Citation |
Shields L, Daniels M, Mar N, Rezazadeh Kalebasty A. Thromboembolic events in metastatic testicular cancer treated with cisplatin-based chemotherapy. World J Clin Oncol 2021; 12(3): 183-194 |
| URL |
https://www.wjgnet.com/2218-4333/full/v12/i3/183.htm |
| DOI |
https://dx.doi.org/10.5306/wjco.v12.i3.183 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
